. "120138-50-3"^^ . "23OW28RS7P"^^ . . "Pharmacologic Substance"^^ . . "Virginiamycin S1, 4-(4-(dimethylamino)-N-methyl-L-phenylalanine)-5-(5-((1-azabicyclo(2.2.2)oct-3-ylthio)methyl)-4-oxo-L-2-piperidinecarboxylic Acid)-,(S)-SNNCI" . "C0756081"^^ . "C47701"^^ . "Quinupristin"^^ . "FDA"^^ . "Quinupristin"^^ . "N-((6R,9S,10R,13S,15aS,18R,22S,24aS)-22-(p-(Dimethylamino)benzyl)-6-ethyldocosahydro-10,23-dimethyl-5,8,12,15,17,21,24-heptaoxo-13-phenyl-18-(((3S)-3-quinuclidinylthio)methyl)-12H-pyrido(2,1-f)pyrrolo(2,1-l)(1,4,7,10,13,16)oxapentaazacyclononadecin-9-yl)-3-hydroxypicolinamideSNNCI" . "QuinupristinPTNCI" . "Quinupristin"^^ . "QUINUPRISTINPTFDA23OW28RS7P" . . . "C53H67N9O10S"^^ . . "A semi-synthetic derivative of pristinamycin, a natural occurring type B streptogramin. Quinupristin binds to the bacterial 50S ribosomal subunit, thereby inhibiting peptide chain elongation, and causing early termination of normal bacterial protein synthesis. Quinupristin is primarily effective against gram-positive cocci.NCI" .